↓ Skip to main content

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control

Overview of attention for article published in BMC Pulmonary Medicine, January 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
15 X users

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
78 Mendeley
Title
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
Published in
BMC Pulmonary Medicine, January 2009
DOI 10.1186/1471-2466-9-1
Pubmed ID
Authors

Mike Thomas, David Price, Henry Chrystyn, Andrew Lloyd, Angela E Williams, Julie von Ziegenweidt

Abstract

As more inhaled corticosteroid (ICS) devices become available, there may be pressure for health-care providers to switch patients with asthma to cheaper inhaler devices. Our objective was to evaluate impact on asthma control of inhaler device switching without an accompanying consultation in general practice.

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Japan 1 1%
Spain 1 1%
Netherlands 1 1%
Unknown 74 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 19%
Other 9 12%
Student > Postgraduate 8 10%
Student > Ph. D. Student 7 9%
Professor 6 8%
Other 13 17%
Unknown 20 26%
Readers by discipline Count As %
Medicine and Dentistry 27 35%
Pharmacology, Toxicology and Pharmaceutical Science 8 10%
Psychology 4 5%
Agricultural and Biological Sciences 3 4%
Economics, Econometrics and Finance 3 4%
Other 8 10%
Unknown 25 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2022.
All research outputs
#1,459,811
of 23,864,146 outputs
Outputs from BMC Pulmonary Medicine
#62
of 2,029 outputs
Outputs of similar age
#5,876
of 174,082 outputs
Outputs of similar age from BMC Pulmonary Medicine
#1
of 5 outputs
Altmetric has tracked 23,864,146 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,029 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,082 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them